Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2

BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) has been shown to exert a synergistic antitumor effect when combined with fluoropyrimidine. This synergy may be attributable to the downregulation of thymidylate synthase (TS), which is frequently overexpressed in fluo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Hwang-Phill, Yoon, Young-Kwang, Kim, Jin-Won, Han, Sae-Won, Hur, Hyung-Seok, Park, Jinah, Lee, Ju-Hee, Oh, Do-Youn, Im, Seock-Ah, Bang, Yung-Jue, Kim, Tae-You
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2009
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2691960/
https://ncbi.nlm.nih.gov/pubmed/19529774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0005933
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars